Phillips Andrew John has filed 8 insider transactions across 3 companies since February 2023.
Most recent transaction: a grant/award of 6682 shares of MoonLake Immunotherapeutics ($MLTX) on June 05, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2025 | MoonLake Immunotherapeutics | $MLTX | Phillips Andrew John | Director | A | Option to Buy | 6682 | $0.00 | 6,682.0000 | 62,870,237 | 9999.99% | 0.01% |
| May 28, 2025 | OnKure Therapeutics, Inc. | $OKUR | Phillips Andrew John | Not found | A | Stock Option (right to buy) | 7650 | $0.00 | 7,650.0000 | 3,447,071 | 9999.99% | 0.22% |
| Feb. 6, 2025 | Enliven Therapeutics, Inc. | $ELVN | Phillips Andrew John | Not found | A | Stock Option (right to buy) | 20491 | $0.00 | 20,491.0000 | 47,072,532 | 9999.99% | 0.04% |
| Oct. 4, 2024 | OnKure Therapeutics, Inc. | $OKUR | Phillips Andrew John | Not found | A | Stock Option (right to buy) | 15300 | $0.00 | 15,300.0000 | 316,142 | 9999.99% | 4.84% |
| June 6, 2024 | MoonLake Immunotherapeutics | $MLTX | Phillips Andrew John | Director | A | Option to Buy | 7688 | $0.00 | 7,688.0000 | 49,122,534 | 9999.99% | 0.02% |
| Feb. 13, 2024 | Enliven Therapeutics, Inc. | $ELVN | Phillips Andrew John | Not found | A | Stock Option (right to buy) | 23364 | $0.00 | 23,364.0000 | 35,546,215 | 9999.99% | 0.07% |
| Feb. 13, 2024 | Enliven Therapeutics, Inc. | $ELVN | Phillips Andrew John | Not found | A | Stock Option (right to buy) | 16835 | $0.00 | 16,835.0000 | 35,546,215 | 9999.99% | 0.05% |
| Feb. 23, 2023 | Enliven Therapeutics, Inc. | $ELVN | Phillips Andrew John | Director | A | Stock Option (right to buy) | 27567 | $0.00 | 27,567.0000 | 0 | 9999.99% | 0.00% |